The global breast reconstruction market is predicted to grow at a CAGR of 7.52% from a market value of US$1,149.150 million in 2020 to reach a market value of US$1,909.147 million by the end of 2027.
Breast reconstruction is referred to as a surgical procedure that involves the restoration of the shape of breasts after a mastectomy procedure. Mastectomy is required to treat or prevent a patient from breast cancer. Hence, with the growing incidences of breast cancer globally, the market is projected to show strong growth prospects during the forecast period. Also, the growing demand for immediate breast reconstruction procedures following mastectomy further allows the market to thrive in the forecast period.
Reconstruction surgery involves implants to reshape the breasts or may involve reconstruction using their body tissues. Other types of reconstruction to reshape breasts include breast reduction, breast lift, and revision of scar.
Furthermore, with technological advancements and companies offering varied products in the form of implants or mesh, the market for breast reconstruction holds favourable growth prospects during the forecast period.
Based on geography, North America and Europe are projected to hold a significant market share in the global breast reconstruction market with advanced healthcare facilities. Additionally, prominent market players offering advanced breast reconstruction products are further propelling the market growth in these regions during the forecast period. For example, Sientra, a public medical device company headquartered in Santa Barbara, CA, United States, offers breast implants with high-strength cohesive silicone gel. The FDA-approved breast implants are available to board-certified and board-eligible plastic surgeons only.
On the other hand, the Asia Pacific region is projected to grow with a high growth rate over the next five years due to increasing awareness regarding breast reconstruction procedures.
During Covid-19, breast reconstruction has taken a back as the healthcare sector was focused on dealing with the disease outbreak. The time demanded to deal with the coronavirus patient was given priority treatment over all the other treatments; procedures were put on hold, and burn of heat had to be borne by aesthetic surgeons. Breast reconstruction is majorly required by breast cancer patients immediately after breast cancer surgery. According to the Journal of Plastic, Reconstructive, and Aesthetic Surgery in February 2022, oncologic breast treatments and reconstructive surgeries dropped significantly by 6.8 percent and 11 percent, respectively, in 2020 compared to 2019.
The growing demand for plastic surgery among consumers will continue to increase the market demand during the forecast period.
According to a press release in September 2018 by the American Society of Plastic Surgeons (ASPS), a new survey reveals that board-certified plastic surgeons are keenly interested in adopting novel techniques, procedures, and advancements over the next ten years to keep pace with the surging consumer demands for various procedures. This is mainly because the demand for plastic surgery is soaring yearly among consumers. It was noticed that in 2017, over 17.5 million surgical and minimally invasive cosmetic procedures were done in the United States. The American Society of Plastic Surgeons, as per their survey, predicted the following emerging consumer trends regarding cosmetic and reconstructive surgery for the next ten years. Over the next ten years, it was analyzed that with solid prospects beneath the skin, cosmetic or plastic surgeons seeking advancements in skin tightening, scar management, fat grafting, and proper surgical training and certification are the top priorities.
On the other hand, it was realized that breast augmentation, tummy tucks, and liposuction are the most popular cosmetic surgical procedures. Also, regarding minimally invasive surgery, Botox is leading and is anticipated to be in high demand. This is further predicted by fillers, chemical peels, laser hair removal, dermabrasion, non-invasive fat reduction, and non-surgical skin tightening.
Furthermore, according to the March 2017press release by the ASPS, it was estimated by the American Cancer Society that in 2017, around 252,710 new cases of invasive breast cancer were projected to be diagnosed in the United States. In the previous year, breast reconstruction accounted for more than 100,000 surgeries. Steady growth was observed annually, accounting for over 30% of breast construction procedural volumes since 2000. In addition, around a 3% increase has been noticed since 2015. Besides, a parallel rise in patient-driven requests was also observed by the plastic surgeons for bilateral mastectomy along with immediate breast reconstruction. Hence, this indicates that with ongoing cancer treatments that include mastectomy, the market's strong growth potential increases during the forecast period. At present, there are over 3 million cancer survivors in the USA. Many of them are potential candidates for delayed breast reconstruction. Also, some candidates require revisions of their previous breast reconstruction, further fueling the market demand over the next five years.
January 2022, Mentor Worldwide LLC, the leading breast aesthetics company and a subsidiary of Johnson & Johnson Medical Devices Companies, announced that the MENTOR MemoryGel BOOSTTM Breast Implant has been authorised by the U.S. Food and Drug Administration for breast augmentation in women over the age of 22, as well as for women of all ages enduring breast reconstruction.
October 2021, Sientra, Inc., a medical aesthetics firm focused solely on plastic surgery, and Mission Plasticos, a non-profit organization committed to providing reconstructive surgical care to those in underserved populations worldwide, announced the launch of Reshaping Lives: Full Circle, a country wide program designed to offer reconstructive breast surgery to post-mastectomy women living in poverty.
May 2021, PERLE, the next generation of breast implants from GC Aesthetics, is an innovative round breast implant with Revolutionary BioQ–surface tech and highly concise Emunomic Breast Tissue Dynamic Gel that was introduced in Europe.
|Market size value in 2020||US$1,149.150 million|
|Market size value in 2027||US$1,909.147 million|
|Growth Rate||CAGR of 7.52% from 2020 to 2027|
|Forecast Unit (Value)||USD Million|
|Segments covered||Type, Mastectomy, End-User, And Geography|
|Regions covered||North America, South America, Europe, Middle East and Africa, Asia Pacific|
|Companies covered||Johnson & Johnson Services, Inc., Allergan plc, Ideal Implant Incorporated, Integra LifeSciences Corporation, RTI Surgical Holdings, Inc., Sientra, Inc.|
|Customization scope||Free report customization with purchase|
Frequently Asked Questions (FAQs)
Q1. What will be the breast reconstruction market size by 2027?
A1. The global breast reconstruction market is predicted to reach a market size of US$1,909.147 million by 2027.
Q2. What is the size of the global breast reconstruction market?
A2. Breast Reconstruction market was valued at US$1,149.150 million in 2020.
Q3. What are the growth prospects for the breast reconstruction market?
A3. The breast reconstruction market is predicted to grow at a CAGR of 7.52% over the forecast period.
Q4. What factors are anticipated to drive the breast reconstruction market growth?
A4. With the growing incidences of breast cancer at the global level, the breast reconstruction market is projected to show strong growth prospects during the forecast period.
Q5. Which region holds the largest market share in the breast reconstruction market?
A5. North America and Europe are projected to hold significant market share in the global breast reconstruction market with advanced healthcare facilities in these regions.
Johnson & Johnson Services, Inc.
Ideal Implant Incorporated
Integra LifeSciences Corporation
RTI Surgical Holdings, Inc.
All our studies come with 2 months of analyst support.
We are in compliance with the global privacy laws.